The METTL3/IGF2BP1 axis-mediated m6 A modification of TRIM11 mRNA suppresses ferroptosis and accelerates malignant progression in non-small cell lung cancer cells by degrading ACSL4

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  2025-07-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00210-025-04207-7PMID 40668412
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA Damage-Induced Ferroptosis: A Boolean Model Regulating p53 and Non-Coding RNAs in Drug Resistance

  2025cited by this paper
• METTL3 drives NSCLC metastasis by enhancing CYP19A1 translation and oestrogen synthesis

  2024cited by this paper
• Correction: TRIM11 facilitates chemoresistance in nasopharyngeal carcinoma by activating the β-catenin/ABCC9 axis via p62-selective autophagic degradation of Daple

  2024cited by this paper
• Epigallocatechin gallate modulates ferroptosis through downregulation of tsRNA-13502 in non-small cell lung cancer

  2024cited by this paper
• Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy.

  2023cited by this paper
• TRIM11 promotes cell proliferation of non‐small cell lung cancer through the inhibition of ferroptosis by AMPK

  2023influential reference
• Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism

  2023cited by this paper
• TRIM11 expression in non-small cell lung cancer is associated with poor prognosis.

  2023cited by this paper
• Targeting m6A binding protein YTHDFs for cancer therapy.

  2023cited by this paper
• The role of m6A methylation in therapy resistance in cancer

  2023cited by this paper
• Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma

  2023cited by this paper
• METTL3 promotes the malignancy of non-small cell lung cancer by N6-methyladenosine modifying SFRP2

  2023cited by this paper
• TRIM11 regulated by m6A modification promotes the progression of cervical cancer by PHLPP1 ubiquitination.

  2023cited by this paper
• The role of m6A demethylases in lung cancer: diagnostic and therapeutic implications

  2023cited by this paper
• Inhibition of LSD1 induces ferroptosis through the ATF4-xCT pathway and shows enhanced anti-tumor effects with ferroptosis inducers in NSCLC

  2023cited by this paper
• TFAP4 activates IGF2BP1 and promotes progression of non-small cell lung cancer by stabilizing TK1 expression through m6A modification.

  2022cited by this paper
• The role of m6A RNA methylation in cancer metabolism

  2022cited by this paper
• CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4.

  2022cited by this paper
• Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment

  2022cited by this paper
• Design and prediction ADME/Tox properties of novel Magnolol derivatives as anticancer agents for NSCLC using 3D-QSAR, Molecular Docking, MOLCAD and MM-GBSA studies

  2022cited by this paper
• Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

  2022cited by this paper
• Allosteric Regulation of IGF2BP1 as a Novel Strategy for the Activation of Tumor Immune Microenvironment

  2022cited by this paper
• Correction: m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC

  2022cited by this paper
• CircEZH2/miR-133b/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m6A-modified CREB1 mRNA

  2022cited by this paper
• Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications.

  2022cited by this paper
• MNX1-AS1 promotes phase separation of IGF2BP1 to drive c-Myc-mediated cell cycle progression and proliferation in lung cancer.

  2022cited by this paper
• RM2Target: a comprehensive database for targets of writers, erasers and readers of RNA modifications

  2022cited by this paper
• Correction: METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way

  2022cited by this paper
• SOX13/TRIM11/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer

  2021cited by this paper
• Ferroptosis in Non-Small Cell Lung Cancer: Progression and Therapeutic Potential on It

  2021cited by this paper
• M6A RNA methylation-mediated RMRP stability renders proliferation and progression of non-small cell lung cancer through regulating TGFBR1/SMAD2/SMAD3 pathway

  2021cited by this paper
• ACSL family: The regulatory mechanisms and therapeutic implications in cancer.

  2021cited by this paper
• m6A RNA methylation and beyond - the epigenetic machinery and potential treatment options.

  2021cited by this paper
• Tripartite motif protein 11 (TRIM11), an oncogene for human lung cancer via the DUSP6-mediated ERK1/2 signaling pathway

  2021cited by this paper
• IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer

  2021cited by this paper
• TRIM11 Promotes Proliferation, Migration, Invasion and EMT of Gastric Cancer by Activating β-Catenin Signaling

  2021cited by this paper
• Roles of METTL3 in cancer: mechanisms and therapeutic targeting

  2020cited by this paper
• Ferroptosis: molecular mechanisms and health implications

  2020cited by this paper
• Epigenetic Modifications of c-MYC: Role in Cancer Cell Reprogramming, Progression and Chemoresistance.

  2020cited by this paper
• TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α

  2020cited by this paper
• TRIM11 promotes tumor angiogenesis via activation of STAT3/VEGFA signaling in lung adenocarcinoma.

  2019cited by this paper
• Recognition of RNA N6-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation

  2018cited by this paper
• FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer

  2017cited by this paper
• TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis.

  2017cited by this paper
• SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features

  2016cited by this paper
• Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

  2015cited by this paper
• Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44

  2010cited by this paper
• Naunyn-Schmiedeberg's archives of pharmacology

  2005cited by this paper
• Implications

  1978cited by this paper

• Nrf2 functions as a biomarker and therapeutic target in lung cancer based on bibliometric analysis and molecular mechanisms

  2025cites this paper